Merck Will Help Expand Access to HIV/AIDS Treatment In Least Developed Countries
Aggregated Source: ChinaCSR.com
February 14, 2007|
Merck has announced a reduction in the price of its HIV/AIDS medicine, STOCRIN (efavirenz), in the least developed countries of the world and those hardest hit by the epidemic.
Original URL: Click here to visit original article
Copyright ChinaCSR.com
|
Original URL: Click here to visit original article
Copyright ChinaCSR.com
Email This Post